B
BBOT//CIK 0001869105
BridgeBio Oncology Therapeutics, Inc.
Market Data
$3.93−$5.44 (−58.06%)
BBOT · Last trade
Prev Close
$9.37
Range (31d)
$3.93 – $9.37
Recent Filings
- 8-K5.0 MBBridgeBio Oncology Therapeutics, Inc.Sep 8, 4:19 PM ET·0001193125-26-385225
- 10-Q10.8 MBBridgeBio Oncology Therapeutics, Inc.Aug 11, 4:12 PM ET·0001193125-26-344661
- 8-K416.8 KBBridgeBio Oncology Therapeutics, Inc.Aug 11, 4:07 PM ET·0001193125-26-344608
- 8-K148.3 KBBridgeBio Oncology Therapeutics, Inc.Jun 22, 4:05 PM ET·0001193125-26-277513
- 10-Q12.7 MBBridgeBio Oncology Therapeutics, Inc.May 12, 5:11 PM ET·0001193125-26-219829
- 8-K390.2 KBBridgeBio Oncology Therapeutics, Inc.May 12, 5:07 PM ET·0001193125-26-219801
- 8-K144.1 KBBridgeBio Oncology Therapeutics, Inc.Apr 29, 4:05 PM ET·0001193125-26-191512
- 8-K184.3 KBBridgeBio Oncology Therapeutics, Inc.Apr 22, 5:31 PM ET·0001193125-26-170888
- 8-K143.4 KBBridgeBio Oncology Therapeutics, Inc.Mar 26, 4:52 PM ET·0001193125-26-126493
- 8-K784.9 KBBridgeBio Oncology Therapeutics, Inc.Mar 5, 4:15 PM ET·0001193125-26-093997
Insiders
10- Bauer JakeDirector
- Beltran PedroDirector, President and CEO
- Ben YongChief Med & Dev Officer
- BridgeBio Pharma, Inc.10% Owner
- BridgeBio Pharma LLC10% Owner
- Chen BihuaDirector, 10% Owner
- Cobo MarcPrincipal Accounting Officer
- DOIG MICHELLEDirector
- Elmelech IdanCOO & Principal Financial Ofcr
- Helix Holdings II LLCDirector, 10% Owner
Tickers
Addresses
business
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA, 94080
mailing
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Helix Acquisition Corp. II2025-08-06